Chronic Pain Clinical Trial
Official title:
A Cognitive-Behaviour Therapy (CBT) Self-Management Approach for Insomnia in Chronic Pain: A Randomized Control Trial
Verified date | August 2017 |
Source | Ottawa Hospital Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will test the impact of a cognitive-behavioural self-management approach for the management of insomnia among patients with chronic pain. This self-management approach consists of a manual describing cognitive behavioural techniques for the management of insomnia. In terms of primary outcomes, it is anticipated that there would be improvements in sleep-related dimensions such as sleep quality, sleep efficiency, and night-time awakenings in the sample group receiving a copy of the self-help manual intervention to be implemented by participants in their home (intervention group), relative to the group receiving treatment as usual (control group). In terms of secondary outcomes, it is anticipated that the intervention group will show improvements in mood, fatigue, pain severity, and pain-related disability relative to the control group. The tertiary outcome variable of pre-sleep arousal is anticipated to have a moderating or mediating relationship with the sleep variables investigated.
Status | Completed |
Enrollment | 48 |
Est. completion date | March 2012 |
Est. primary completion date | January 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 18 to 65 years of age - Not in state of crisis - Able to read and understand English - Experiences sleep difficulties or insomnia - Has chronic pain Exclusion Criteria: - Under 18 or over 65 years of age - In a state of crisis - Does not read or understand English - Does not experience sleep difficulties or insomnia - Does not have chronic pain |
Country | Name | City | State |
---|---|---|---|
Canada | The Ottawa Hospital Rehabilitation Centre | Ottawa | Ontario |
Canada | The Ottawa Hospital, Pain Clinic | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Ottawa Hospital Research Institute | The Ottawa Hospital |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insomnia Severity Index (ISI) | Measures insomnia symptoms, scores range from 0-28 with higher scores (ranging from 15-28) indicating clinical insomnia and therefore worse outcomes | Timepoint 2 (week 7 of study participation) | |
Primary | Sleep Diary- Total Sleep Time | Measures: Total Sleep Time in hours, higher scores indicate better outcomes |
Timepoint 2 (week 7 of study participation). | |
Primary | Sleep Diary- Time to Fall Asleep | Measures: Time to Fall Asleep in minutes, higher scores indicate worse outcomes |
Timepoint 2 (week 7 of study participation). | |
Primary | Sleep Diary- Number of Nocturnal Awakenings | Measures: Number of Nocturnal Awakenings, higher scores indicate worse outcomes |
Timepoint 2 (week 7 of study participation). | |
Primary | Sleep Diary- Sleep Efficiency | Measures: Sleep Efficiency (percentage)- higher scores indicate better outcomes |
Timepoint 2 (week 7 of study participation). | |
Primary | Sleep Diary- Sleep Quality | Measures: Sleep Quality (units on a scale from 0-10), higher scores indicate better outcomes |
Timepoint 2 (week 7 of study participation). | |
Secondary | Pain Severity Rating | Measures pain severity, rated on scale from 0-10, total scores range from 0-40, higher scores indicate worse outcomes | Timepoint 2 (week 7 of study participation). | |
Secondary | Pain Disability Index (PDI) | Measures pain disability impact on various life domains, scores range from 0-70, higher scores indicate worse outcomes | Timepoint 2 (week 7 of study participation). | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | Measures symptoms of depression and anxiety, total scores range from 0-42, higher scores indicate worse outcomes | Timepoint 2 (week 7 of study participation). | |
Secondary | Pre-Sleep Arousal Scale (PSAS) | Measures pre-sleep hyperarousal, total scores range from 16-80, higher scores indicate worse outcomes | Timepoint 2 (week 7 of study participation). | |
Secondary | Fatigue Severity Scale (FSS) | Measures symptoms of fatigue, total scores range from 9-63, higher scores indicate worse outcomes | Timepoint 2 (week 7 of study participation). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|